<![CDATA[Nyt studie (52) med ofatumumab:]]>Nyt studie (52) med ofatumumab:

Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
This study is not yet open for participant recruitment.
Verified by National Cancer Institute (NCI), January 2011
First Received: January 27, 2011 No Changes Posted

Sponsor: Cancer and Leukemia Group B
Collaborator: National Cancer Institute (NCI)

]]>https://dev.proinvestor.com/forum/topic/448350/nyt-studie-52-med-ofatumumabRSS for NodeSun, 21 Jun 2026 06:19:49 GMTWed, 02 Feb 2011 16:33:18 GMT60